All Stories

  1. Stat3 in intestinal regeneration and tumorigenesis
  2. NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells
  3. Mutant p53 in colon cancer
  4. Dietary intake of pyrolyzed deketene curcumin inhibits gastric carcinogenesis
  5. Author Correction: Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer
  6. Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer
  7. Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress
  8. The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion
  9. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development
  10. Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers
  11. Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer
  12. Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
  13. Laser Microdissection of Cellular Compartments for Expression Analyses in Cancer Models
  14. Combined Mutation ofApc, Kras, andTgfbr2Effectively Drives Metastasis of Intestinal Cancer
  15. Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism
  16. A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer
  17. Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts
  18. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation
  19. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer
  20. Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes
  21. Nardilysin regulates inflammation, metaplasia and tumors in murine stomach
  22. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2 -Mediated Suppression of Antitumor Immunity
  23. 18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling
  24. Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E 2 and Toll‐like receptor/MyD88 pathways
  25. Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment
  26. NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition
  27. Dipeptide species regulate p38MAPK–Smad3 signalling to maintain chronic myelogenous leukaemia stem cells
  28. Ink4a/Arf-Dependent Loss of Parietal Cells Induced by Oxidative Stress Promotes CD44-Dependent Gastric Tumorigenesis
  29. Canolol Inhibits Gastric Tumors Initiation and Progression through COX-2/PGE2 Pathway in K19-C2mE Transgenic Mice
  30. Suppressing TGF  Signaling in Regenerating Epithelia in an Inflammatory Microenvironment Is Sufficient to Cause Invasive Intestinal Cancer
  31. PGE2-Associated Inflammation and Gastrointestinal Tumorigenesis
  32. Therapeutic activity of glycoengineered anti‐ GM 2 antibodies against malignant pleural mesothelioma
  33. Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo
  34. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1
  35. Context‐dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells
  36. Impact of Inflammation–Metaplasia–Adenocarcinoma Sequence and Inflammatory Microenvironment in Esophageal Carcinogenesis Using Surgical Rat Models
  37. Requirement of SLD5 for Early Embryogenesis
  38. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells
  39. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia
  40. Claudin-4 Deficiency Results in Urothelial Hyperplasia and Lethal Hydronephrosis
  41. Validation of MIMGO: a method to identify differentially expressed GO terms in a microarray dataset
  42. Toll-like receptor 2: therapeutic target for gastric carcinogenesis
  43. The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner
  44. The role of PGE2-associated inflammatory responses in gastric cancer development
  45. STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
  46. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models
  47. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells
  48. Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence
  49. CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
  50. Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis
  51. Prostaglandin E2 Signaling and Bacterial Infection Recruit Tumor-Promoting Macrophages to Mouse Gastric Tumors
  52. Adenomatous polyposis coli heterozygous knockout mice display hypoactivity and age-dependent working memory deficits
  53. Suppression of Colon Cancer Metastasis by Aes through Inhibition of Notch Signaling
  54. Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.
  55. Mouse models of gastric tumors: Wnt activation and PGE2 induction
  56. Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development
  57. CD44+slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2in gastric tumorigenesis
  58. Hepatocellular carcinoma development induced by conditional β-catenin activation inLkb1+/−mice
  59. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin
  60. Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models
  61. HMGA1 Is Induced by Wnt/β-Catenin Pathway and Maintains Cell Proliferation in Gastric Cancer
  62. Induction and Down-regulation of Sox17 and Its Possible Roles During the Course of Gastrointestinal Tumorigenesis
  63. Induction of Prostaglandin E2 Pathway Promotes Gastric Hamartoma Development with Suppression of Bone Morphogenetic Protein Signaling
  64. The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development
  65. Prostaglandin and Transforming Growth Factor β Signaling in Gastric Cancer
  66. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer
  67. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and β-catenin activation in gastric carcinogenesis inN-methyl-N-nitrosourea-treated K19-C2mE transgenic mice
  68. Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas
  69. Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells
  70. Stromal Fibroblasts Activated by Tumor Cells Promote Angiogenesis in Mouse Gastric Cancer
  71. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
  72. Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency
  73. Suppression of Tubulin Polymerization by the LKB1-Microtubule-associated Protein/Microtubule Affinity-regulating Kinase Signaling
  74. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion
  75. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
  76. Increased Level of Serum Vascular Endothelial Growth Factor by Long-Term Exposure to Hypergravity
  77. Chromosomal instability by β-catenin/TCF transcription in APC or β-catenin mutant cells
  78. Carcinogenesis in Mouse Stomach by Simultaneous Activation of the Wnt Signaling and Prostaglandin E2 Pathway
  79. Destruction of Pancreatic β-Cells by Transgenic Induction of Prostaglandin E2in the Islets
  80. Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/−p53−/− compound mutant mice
  81. Hyperplastic Gastric Tumors with Spasmolytic Polypeptide–Expressing Metaplasia Caused by Tumor Necrosis Factor-α–Dependent Inflammation in Cyclooxygenase-2/Microsomal Prostaglandin E Synthase-1 Transgenic Mice
  82. The Threshold Level of Adenomatous Polyposis Coli Protein for Mouse Intestinal Tumorigenesis
  83. Hypergravity induces expression of cyclooxygenase-2 in the heart vessels
  84. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles
  85. A Targeted Mutation of Nkd1 Impairs Mouse Spermatogenesis
  86. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice
  87. Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes
  88. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice
  89. Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas
  90. Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
  91. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2 +/− compound mutant mice
  92. Targeted Disruption of the Mouse Rho-Associated Kinase 2 Gene Results in Intrauterine Growth Retardation and Fetal Death
  93. Requirement for tumor suppressor Apc in the morphogenesis of anterior and ventral mouse embryo
  94. COX Selectivity and Animal Models for Colon Cancer
  95. COX inhibitor, suppression of polyposis, and chemoprevention.
  96. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc Δ716 knockout mice
  97. Morphologic and Molecular Analysis of Estrogen-Induced Pituitary Tumorigenesis in Targeted Disruption of Transforming Growth Factor-β Receptor Type II and/or p27 Mice
  98. Optimization of the helper-dependent adenovirus system for production and potency in vivo
  99. Intestinal polyposis in mice with a dominant stable mutation of the beta -catenin gene
  100. Impaired extrapyramidal function caused by the targeted disruption of Retinoid X receptor RXRgamma1 isoform
  101. Estrogen-induced tumorigenesis in the pituitary gland of TGF-β(+/−) knockout mice
  102. Nuclear translocation of beta-catenin in hereditary and carcinogen- induced intestinal adenomas
  103. Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
  104. Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice
  105. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene ( Trsp )
  106. Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
  107. TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
  108. Early Embryonic Lethality Caused by Targeted Disruption of the Mouse Thioredoxin Gene
  109. Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in ApcΔ716 knockout mice
  110. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.
  111. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in ApcΔ716 knockout mice